Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nephros (NEPH) Accumulated Expenses (2016 - 2025)

Historic Accumulated Expenses for Nephros (NEPH) over the last 17 years, with Q3 2025 value amounting to $1.2 million.

  • Nephros' Accumulated Expenses rose 25745.34% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year increase of 25745.34%. This contributed to the annual value of $565000.0 for FY2024, which is 2884.13% down from last year.
  • Latest data reveals that Nephros reported Accumulated Expenses of $1.2 million as of Q3 2025, which was up 25745.34% from $771000.0 recorded in Q2 2025.
  • In the past 5 years, Nephros' Accumulated Expenses registered a high of $1.2 million during Q3 2025, and its lowest value of $185000.0 during Q2 2022.
  • Its 5-year average for Accumulated Expenses is $502789.5, with a median of $444000.0 in 2021.
  • As far as peak fluctuations go, Nephros' Accumulated Expenses tumbled by 6113.45% in 2022, and later soared by 25745.34% in 2025.
  • Quarter analysis of 5 years shows Nephros' Accumulated Expenses stood at $444000.0 in 2021, then crashed by 35.81% to $285000.0 in 2022, then skyrocketed by 178.6% to $794000.0 in 2023, then decreased by 28.84% to $565000.0 in 2024, then skyrocketed by 103.72% to $1.2 million in 2025.
  • Its Accumulated Expenses was $1.2 million in Q3 2025, compared to $771000.0 in Q2 2025 and $603000.0 in Q1 2025.